KRYS logo

Krystal Biotech (KRYS) Company Overview

Profile

Full Name:

Krystal Biotech, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

September 20, 2017

Indexes:

Not included

Description:

Krystal Biotech is a manufacturer of gene therapy drugs, engaged in their clinical development and striving to create and bring to market modern drugs for patients with skin diseases. The company has developed and patented a gene therapy platform that allows for the development of ready-to-use treatments for skin diseases that cannot be cured by known methods. Krystal Biotech, Inc. was founded in 2015, with its headquarters located in Pittsburgh, Pennsylvania.

Key Details

Price

$180.50

Annual Revenue

$290.51 M(+473.02% YoY)

Annual EPS

$3.00(+669.23% YoY)

Beta

1.19

Events Calendar

Earnings

Next earnings date:

May 6, 2025

Recent quarterly earnings:

Feb 19, 2025

Recent annual earnings:

Feb 19, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 20, 25 Citigroup
Neutral
Feb 20, 25 Chardan Capital
Buy
Feb 20, 25 Cantor Fitzgerald
Overweight
Feb 19, 25 HC Wainwright & Co.
Buy
Dec 18, 24 HC Wainwright & Co.
Buy
Dec 18, 24 Chardan Capital
Buy
Dec 13, 24 HC Wainwright & Co.
Buy
Dec 12, 24 Chardan Capital
Buy
Dec 10, 24 HC Wainwright & Co.
Buy
Nov 5, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Krystal Biotech?
  • Does Krystal Biotech pay dividends?
  • What sector is Krystal Biotech in?
  • What industry is Krystal Biotech in?
  • What country is Krystal Biotech based in?
  • When did Krystal Biotech go public?
  • Is Krystal Biotech in the S&P 500?
  • Is Krystal Biotech in the NASDAQ 100?
  • Is Krystal Biotech in the Dow Jones?
  • When was Krystal Biotech's last earnings report?
  • When does Krystal Biotech report earnings?
  • Should I buy Krystal Biotech stock now?

What is the ticker symbol for Krystal Biotech?

The ticker symbol for Krystal Biotech is NASDAQ:KRYS

Does Krystal Biotech pay dividends?

No, Krystal Biotech does not pay dividends

What sector is Krystal Biotech in?

Krystal Biotech is in the Healthcare sector

What industry is Krystal Biotech in?

Krystal Biotech is in the Biotechnology industry

What country is Krystal Biotech based in?

Krystal Biotech is headquartered in United States

When did Krystal Biotech go public?

Krystal Biotech's initial public offering (IPO) was on September 20, 2017

Is Krystal Biotech in the S&P 500?

No, Krystal Biotech is not included in the S&P 500 index

Is Krystal Biotech in the NASDAQ 100?

No, Krystal Biotech is not included in the NASDAQ 100 index

Is Krystal Biotech in the Dow Jones?

No, Krystal Biotech is not included in the Dow Jones index

When was Krystal Biotech's last earnings report?

Krystal Biotech's most recent earnings report was on Feb 19, 2025

When does Krystal Biotech report earnings?

The next expected earnings date for Krystal Biotech is May 6, 2025

Should I buy Krystal Biotech stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions